Pharm Flashcards
(121 cards)
Competitive inhibitor Reversible
Resemble substrate, bind at active site Overcome by increase substrate Vmax: unchanged Km: increased decrease potency
Competitive inhibitor Irreversible
Resemble substrate, bind at active site NOT overcome by increase substrate Vmax: decreased Km: unchanged decrease efficacy
Noncompetitive inhibitor
Resemble substrate, DOES NOT bind at active site NOT overcome by increase substrate Vmax: decreased Km: unchanged decrease efficacy
Bioavailability
Fraction of administered drug reaching systemic circulation unchanged.
IV= 100%
F= AUC oral/ AUC IV
Volume of distribution
Theoretical volume occupied by the total amount of drug in the body relative to its plasma concentration.
Can be altered by liver and kidney disease (high Vd)
Vd= amount of drug in body / plasma concentration
Low –> intravascular
Medium –> ECF
High –> all tissues
Clearance
The time required to change the amount of drug in the body by 1/2 during elimination
First order- t1/2 = (.7*Vd) / CL
Loading dose
Cp*Vd/F
Maintenance dose
(Cp * CL *dosage interval) / F
Zero Order elimination
rate of elimination is constant regardless of Cp
Cp decreased linearly with time
Phenytoin, Ethanol, Aspirin
First order elimination
Directly proportional to drug concentration
Most drugs
Efficacy
Maximal effect a drug can produce
Vmax
Potency
Amount of drug needed for a given effect.
EC50
Competitive antagonist
Decrease potency
No change in efficacy
Can be overcome by increase agonist concentration
Noncompetitive antagonist
No change in potency
Decrease efficacy
Cannot be overcome by increase agonist concentration
Partial agonist
Independent of potency
Efficacy decreases
Therapeutic index
Measure of drug safety
TD50/ ED50
Safe drugs have high therapeutic index
Bladder control
Sympathetics: increase urinary retention
Parasympathetics: increase urine voiding
Urgency incontinence Meds
Muscarinic antagonists (-M3 --> relax detrusor M --> decrease overactivity) Oxybutynin Sympathomimetics (+B3 --> relax detrusor muscle --> increase bladder capacity) Miragegron
Urinary Retention meds
Muscarinic agonist (+M3 –> contract detrusor –> increase bladder emptying) Bethanechol
BPH meds
a1 blockers (-a1 --> relax smooth muscle --> decrease urinary obstruction) Tamsulosin
a1
Gq
increase vascular smooth muscle contraction, Mydriasis, increase intestinal and bladder sphincter muscle contraction
a2
Gi
decrease sympathetics, decrease insulin, decrease lipolysis, increase platelet aggregation, decrease aqueous humor production
B1
Gs
increase HR, contractility, renin, lipolysis
B2
Gs
vasodilation, bronchodilation, increase lipolysis, insulin, glycogenolysis, decrease uterine tone, increase aqueous humor production, increase cellular K+ intake